Garrison Bradford & Associates Inc. purchased a new stake in Medical Properties Trust, Inc. (NYSE:MPW) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 12,000 shares of the real estate investment trust’s stock, valued at approximately $154,000.

A number of other large investors also recently made changes to their positions in MPW. Vanguard Group Inc. increased its stake in shares of Medical Properties Trust by 5.3% in the first quarter. Vanguard Group Inc. now owns 54,229,337 shares of the real estate investment trust’s stock valued at $699,015,000 after buying an additional 2,705,148 shares in the last quarter. BlackRock Inc. increased its stake in shares of Medical Properties Trust by 6,731.8% in the first quarter. BlackRock Inc. now owns 40,047,534 shares of the real estate investment trust’s stock valued at $516,212,000 after buying an additional 39,461,340 shares in the last quarter. Massachusetts Financial Services Co. MA increased its stake in shares of Medical Properties Trust by 1.2% in the first quarter. Massachusetts Financial Services Co. MA now owns 18,150,112 shares of the real estate investment trust’s stock valued at $233,956,000 after buying an additional 211,209 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Medical Properties Trust by 8.9% in the second quarter. Bank of New York Mellon Corp now owns 13,525,447 shares of the real estate investment trust’s stock valued at $174,072,000 after buying an additional 1,109,174 shares in the last quarter. Finally, State Street Corp increased its stake in shares of Medical Properties Trust by 7.1% in the first quarter. State Street Corp now owns 12,202,245 shares of the real estate investment trust’s stock valued at $157,286,000 after buying an additional 811,784 shares in the last quarter. 82.12% of the stock is currently owned by institutional investors.

Medical Properties Trust, Inc. (MPW) opened at 12.82 on Tuesday. Medical Properties Trust, Inc. has a 52 week low of $11.54 and a 52 week high of $15.74. The company has a 50-day moving average of $12.75 and a 200-day moving average of $13.04. The stock has a market capitalization of $4.49 billion, a price-to-earnings ratio of 15.67 and a beta of 0.89.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Wednesday, August 9th. The real estate investment trust reported $0.32 EPS for the quarter, meeting the consensus estimate of $0.32. The business had revenue of $166.80 million for the quarter, compared to analyst estimates of $163.08 million. Medical Properties Trust had a net margin of 42.25% and a return on equity of 7.54%. The company’s quarterly revenue was up 32.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.32 earnings per share. Analysts anticipate that Medical Properties Trust, Inc. will post $0.88 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 12th. Stockholders of record on Thursday, September 14th will be given a $0.24 dividend. The ex-dividend date is Wednesday, September 13th. This represents a $0.96 annualized dividend and a dividend yield of 7.49%. Medical Properties Trust’s dividend payout ratio is presently 115.66%.

WARNING: “Garrison Bradford & Associates Inc. Purchases New Position in Medical Properties Trust, Inc. (MPW)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/08/22/garrison-bradford-associates-inc-purchases-new-position-in-medical-properties-trust-inc-mpw.html.

Several equities research analysts have weighed in on MPW shares. Royal Bank Of Canada reaffirmed a “buy” rating on shares of Medical Properties Trust in a research report on Monday, May 15th. Jefferies Group LLC upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Tuesday, July 4th. ValuEngine upgraded Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Thursday, August 3rd. BidaskClub upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Monday, July 24th. Finally, Deutsche Bank AG raised their target price on Medical Properties Trust from $13.50 to $15.00 and gave the company a “buy” rating in a research report on Tuesday, July 4th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and seven have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $14.20.

In related news, CFO R Steven Hamner sold 85,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total transaction of $1,135,600.00. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.00% of the stock is owned by corporate insiders.

About Medical Properties Trust

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Stock Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related stocks with our FREE daily email newsletter.